Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicacions

  • Yeramian, Andree; Santacana, Maria; Sorolla, Anabel; Llobet, David; Encinas, Mario; Velasco, Ana; Bahi, Nuria; Eritja, Nuria; Domingo, Monica; Oliva, Esther; Dolcet, Xavier; Matias-Guiu, Xavier

    Nuclear factor-?B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1a independent manner.

    LABORATORY INVESTIGATION 91 859-871. .

    [doi:10.1038/labinvest.2011.58]

  • Bernet, Laia; Cano, Rafael; Martinez, Marcos; Duenas, Basilio; Matias-Guiu, Xavier; Morell, Lluisa; Palacios, Jose; Rezola, Ricardo; Robles-Frias, Maria; Ruiz, Irune; Velasco, Ana; Vieites, Begona; Sevilla, Francisco; Torro, Jose; Medrano, Jose; Ballester, Blai

    Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study

    Histopathology 58 863-869. .

    [doi:10.1111/j.1365-2559.2011.03836.x]

  • Llobet, David; Eritja, Nuria; Domingo, Monica; Bergada, Laura; Mirantes, Cristina; Santacana, Maria; Pallares, Judit; Macia, Anna; Yeramian, Andree; Encinas, Mario; Moreno-Bueno, Gema; Palacios, Jose; Lewis, Robert E.; Matias-Guiu, Xavier; Dolcet, Xavi

    KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.

    AMERICAN JOURNAL OF PATHOLOGY 178 1529-1543. .

    [doi:10.1016/j.ajpath.2010.12.041]

  • Vilardell, F.; Velasco, A.; Cuevas, D.; Olsina, J. J.; Matias-Guiu, X.

    Composite papillary intestinal-type adenocarcinoma/poorly differentiated neuroendocrine carcinoma of the ampulla of Vater

    JOURNAL OF CLINICAL PATHOLOGY 64 174-177. .

    [doi:10.1136/jcp.2010.084954]

  • Velasco, Ana; Pallares, Judit; Santacana, Maria; Gatius, Sonia; Fernandez, Melisa; Domingo, Monica; Valls, Joan; Yeramian, Andree; Encinas, Mario; Dolcet, Xavier; Matias-Guiu, Xavier

    Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.

    HUMAN PATHOLOGY 42 185-193. .

    [doi:10.1016/j.humpath.2010.08.001]

  • Gatius, S; Azueta, A; Velasco, A; Santacana, M; Pallares, J; Matias-Guiu, X

    FGFR2 Alterations in Endometrial Carcinoma.

    LABORATORY INVESTIGATION 91 442-442. .

  • Angeles Castilla, Maria; Moreno-Bueno, Gema; Romero-Perez, Laura; Van De Vijver, Koen; Biscuola, Michele; Angeles Lopez-Garcia, Maria; Prat, Jaime; Matias-Guiu, Xavier; Cano, Amparo; Oliva, Esther; Palacios, Jose

    Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

    JOURNAL OF PATHOLOGY 223 72-80. .

    [doi:10.1002/path.2802]

  • Matias-Guiu, Xavier; Oliva, Esther

    Pathology of the Endometrium Introduction

    SEMINARS IN DIAGNOSTIC PATHOLOGY 27 197-198. .

    [doi:10.1053/j.semdp.2010.03.001]

  • Azueta, Ainara; Gatius, Sonia; Matias-Guiu, Xavier

    Endometrioid carcinoma of the endometrium: pathologic and molecular features.

    SEMINARS IN DIAGNOSTIC PATHOLOGY 27 226-240. .

    [doi:10.1053/j.semdp.2010.09.001]

  • Eritja, Nuria; Llobet, David; Domingo, Monica; Santacana, Maria; Yeramian, Andree; Matias-Guiu, Xavier; Dolcet, Xavi

    A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis.

    AMERICAN JOURNAL OF PATHOLOGY 176 2722-2731. .

    [doi:10.2353/ajpath.2010.090974]

  • Garcia, Virginia; Velasco, Ana; Gatius, Sonia; Javier Gonzalez, F.; Matias-Guiu, Xavier

    Pulmonary small cell carcinoma metastatic to the ovary: a clinicopathologic study of one case with emphasis on the importance of p53 analysis in diagnosis.

    GYNECOLOGIC AND OBSTETRIC INVESTIGATION 70 87-90. .

    [doi:10.1159/000292911]

  • Llobet, D.; Eritja, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Domingo, M.; Santacana, M.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.

    The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.

    EUROPEAN JOURNAL OF CANCER 46 836-850. .

    [doi:10.1016/j.ejca.2009.12.025]

Projectes

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU